12/16/2024
6:38 PM | Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
RTW INVESTMENTS, LP (Reporting)
WONG RODERICK (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
6:51 PM | Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13D/A | |
12/12/2024
5:02 AM | Rocket Pharmaceuticals (Filer)
ROCKET PHARMACEUTICALS, INC. (Filer)
| Form 424B5 | |
11/25/2024
3:05 PM | Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Wilson Martin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
3:05 PM | Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Shah Gaurav (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
3:05 PM | Patel Kinnari (Reporting)
Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
3:05 PM | Militello John (Reporting)
Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
11/21/2024
3:26 PM | Patel Kinnari (Reporting)
Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/21/2024
3:06 PM | Militello John (Reporting)
Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/21/2024
2:58 PM | Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Wilson Martin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/21/2024
2:27 PM | Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Shah Gaurav (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/18/2024
3:15 PM | Rocket Pharmaceuticals (Filer)
ROCKET PHARMACEUTICALS, INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
9:52 AM | Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
11/07/2024
3:45 PM | Rocket Pharmaceuticals (Filer)
ROCKET PHARMACEUTICALS, INC. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/31/2024
2:24 PM | Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
White Mark Andrew (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/31/2024
2:34 PM | Militello John (Reporting)
Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/29/2024
4:05 PM | Bjork Elisabeth (Reporting)
Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
3:07 PM | Dolsten Mikael (Reporting)
Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
3:05 PM | Dolsten Mikael (Reporting)
Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/11/2024
3:06 PM | Rocket Pharmaceuticals (Filer)
ROCKET PHARMACEUTICALS, INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/20/2024
3:26 PM | Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Wilson Martin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
3:26 PM | Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Shah Gaurav (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
3:26 PM | Patel Kinnari (Reporting)
Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
3:26 PM | Militello John (Reporting)
Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
2:29 PM | Patel Kinnari (Reporting)
Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/16/2024
2:39 PM | Militello John (Reporting)
Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/16/2024
2:16 PM | Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Shah Gaurav (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/16/2024
2:23 PM | Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Wilson Martin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/06/2024
3:15 PM | Rocket Pharmaceuticals (Filer)
ROCKET PHARMACEUTICALS, INC. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/24/2024
3:05 PM | Militello John (Reporting)
Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/22/2024
2:22 PM | Militello John (Reporting)
Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/09/2024
3:05 PM | Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
White Mark Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
2:17 PM | Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
White Mark Andrew (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2024
9:34 AM | Makker Gotham (Reporting)
Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
| Form 4/A | |
05/20/2024
3:33 PM | Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Shah Gaurav (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
3:36 PM | Militello John (Reporting)
Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
3:39 PM | Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
SOUTHWELL DAVID P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
3:26 PM | Patel Kinnari (Reporting)
Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
3:29 PM | Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Wilson Martin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
3:27 PM | Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Shah Gaurav (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024
2:41 PM | Militello John (Reporting)
Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
What most folks don’t know about oil (BIG missed opportunity) (Ad) $1 Trillion…
That’s how much Big Tech is set to spend on AI investment in the coming months—according to Goldman Sachs.
This investment is driving an A.I. boom that’s being felt across many industries…
Including a specific group of energy tickers since A.I. data centers use a massive amount of power.
One of those tickers is CEG, up nearly 600% in the last 3 years…
Combined with the upcoming presidential election, we have the recipe for a major shakeup in the market.
You see, each time the U.S. elects a new president, one overlooked part of the energy sector tends to see a big move.
Fact is… this energy niche is BOOMING. And expects this underappreciated niche to continue rallying well into 2026. |
05/16/2024
2:41 PM | Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Wilson Martin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024
2:44 PM | Patel Kinnari (Reporting)
Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/07/2024
3:05 PM | Rocket Pharmaceuticals (Filer)
ROCKET PHARMACEUTICALS, INC. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/06/2024
4:26 PM | Rocket Pharmaceuticals (Filer)
ROCKET PHARMACEUTICALS, INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2024
3:42 PM | Rocket Pharmaceuticals (Filer)
ROCKET PHARMACEUTICALS, INC. (Filer)
| Form DEF 14A | |
04/29/2024
3:43 PM | Rocket Pharmaceuticals (Filer)
ROCKET PHARMACEUTICALS, INC. (Filer)
| Form DEFA14A | |
04/29/2024
3:45 PM | Rocket Pharmaceuticals (Filer)
ROCKET PHARMACEUTICALS, INC. (Filer)
| Form ARS | |
04/24/2024
3:06 PM | Militello John (Reporting)
Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2024
2:18 PM | Militello John (Reporting)
Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/17/2024
4:26 PM | Rocket Pharmaceuticals (Filer)
ROCKET PHARMACEUTICALS, INC. (Filer)
| Form PRE 14A | |
04/16/2024
4:45 PM | Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
SOUTHWELL DAVID P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/12/2024
3:11 PM | Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
SOUTHWELL DAVID P (Reporting)
SOUTHWELL DAVID P (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2024
7:39 PM | Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
White Mark Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
2:11 PM | Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
White Mark Andrew (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/05/2024
8:47 AM | Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
04/03/2024
5:02 PM | Ondrey Aaron (Reporting)
Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
5:07 PM | Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Schwartz Jonathan David (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/29/2024
4:17 PM | Rocket Pharmaceuticals (Filer)
ROCKET PHARMACEUTICALS, INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
7:54 PM | Militello John (Reporting)
Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
7:58 PM | Makker Gotham (Reporting)
Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
10:39 AM | Militello John (Reporting)
Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
5:54 PM | Militello John (Reporting)
Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
5:48 PM | Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Wilson Martin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
2:54 PM | Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Wilson Martin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
1:59 PM | Militello John (Reporting)
Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024
3:37 PM | Rocket Pharmaceuticals (Filer)
ROCKET PHARMACEUTICALS, INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/21/2024
7:54 PM | Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Shah Gaurav (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
7:54 PM | Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
White Mark Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
7:54 PM | Militello John (Reporting)
Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
7:54 PM | Patel Kinnari (Reporting)
Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
7:54 PM | Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Wilson Martin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
4:28 PM | Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Shah Gaurav (Reporting)
| Form 144/A | |
02/16/2024
3:31 PM | Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Wilson Martin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/16/2024
3:37 PM | Patel Kinnari (Reporting)
Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/16/2024
3:22 PM | Militello John (Reporting)
Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/16/2024
3:26 PM | Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
Shah Gaurav (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/08/2024
9:17 AM | Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G | |
01/23/2024
3:22 PM | Militello John (Reporting)
Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
3:05 PM | Militello John (Reporting)
Rocket Pharmaceuticals (Issuer)
ROCKET PHARMACEUTICALS, INC. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
2:16 PM | Militello John (Reporting)
Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2024
10:43 AM | Rocket Pharmaceuticals (Subject)
ROCKET PHARMACEUTICALS, INC. (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
